May 21 2026

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these medications could become a major weapon against cardiovascular disease — not just obesity and diabetes.

Read More

From Science Daily • • 0

May 21 2026

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these medications could become a major weapon against cardiovascular disease — not just obesity and diabetes.

Read More

From Science Daily • • 0

May 21 2026

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these medications could become a major weapon against cardiovascular disease — not just obesity and diabetes.

Read More

From Science Daily • • 0

May 21 2026

Popular GLP-1 weight-loss drugs like Ozempic slash heart attack and stroke risk

A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Researchers say these medications could become a major weapon against cardiovascular disease — not just obesity and diabetes.

Read More

From Science Daily • • 0

May 19 2026

People who lost the most weight on Ozempic saw huge health benefits

People who lost significant weight while taking Ozempic, Wegovy, Mounjaro, or Saxenda had sharply lower risks of major obesity-related health problems, including sleep apnea and kidney disease. Those who gained weight instead faced higher risks — especially for heart failure — even though many patients discontinued the medications within a year.

Read More

From Science Daily • • 0